Webinars

Lauren M. Walker, PhD, Project Toxicologist, Pliant Therapeutics

Dr. Lauren Walker is a project toxicologist with experience spanning biotech, consumer product safety, and academic research. She specializes in DART, immunotoxicology, and exposure-based risk assessment, and has served on over 10 career development committees including the Society of Toxicology Graduate Student Leadership Professional Development Subcommittee (Secretary, Chair) and Federation of American Societies for Experimental Biology (FASEB) Diversity, Equity, and Inclusion Committee (Vice-President and Chair). A frequent mentor and speaker, she is passionate about helping fellow toxicologists grow their careers through proactive networking.

Madelyn (Mimi) Huang, PhD, DABT, Toxicologist, Premier Research

Dr. Madelyn “Mimi” Huang is a Toxicologist at Premier Research, a strategic product development and global regulatory consulting company dedicated to supporting the specialized needs of emerging biotech and specialty pharma companies. At Premier, she provides input on nonclinical aspects of therapeutic product development, such as designing nonclinical programs to support clinical studies, reviewing regulatory submissions for global regulatory authorities, and crafting regulatory strategies. Her portfolio covers small molecules, biologics, cell and gene therapies, as well as marketing applications via the FDA’s 505(b)(2) pathway.

Previously, Dr. Huang was a postdoctoral fellow at the Division of Translational Toxicology at the National Toxicology Program, where she designed and managed the conduct of regulatory toxicology studies evaluating various environmental chemicals (e.g., PFAS, phthalates). She obtained her PhD in Toxicology at the University of North Carolina at Chapel Hill and a BS in Biochemistry from the University of Notre Dame. Dr. Huang is a Diplomate of the American Board of Toxicology, from 2022 until present. Dr. Huang has published 18 articles in peer-reviewed journals on topics spanning a wide range of toxicology, from basic environmental chemical research to pharmaceutical regulatory strategy.

Dr. Huang has been a member of the Society of Toxicology since 2012 and of the American College of Toxicology since 2017 and has been an active contributor over the years. She has a passion for helping trainees develop transferable skills and professional networks in industry and has coordinated or supported numerous career development events locally and nationally.

Tynisha D. Glover, PhD, Distinguished Scientist II, Nonclinical Safety Therapeutic Area Lead for Oncology and Cell Therapy Leader for Nonclinical Safety, Johnson & Johnson

Dr. Tynisha Glover is a Distinguished Scientist II, Nonclinical Safety Therapeutic Area Lead for Oncology and Cell Therapy Leader for Nonclinical Safety. In her role, she provides nonclinical safety leadership for the nonclinical safety aspects of the CAR-T cell and biologics oncology portfolio in discovery and development primarily in the multiple myeloma, lymphoma/leukemia and prostate disease areas.  Additionally, she interfaces with worldwide regulatory agencies and represents Johnson & Johnson on professional cross-industry initiatives, including but not limited to, a member of the leadership team of the CAR-T consortium and Co-chair of BIO’s Cell and Gene Therapy task force and an active member of the Society of Toxicology.